B. Riley将Centessa Pharmaceuticals评级从买入下调至中性，目标价上调至45美元

美股速递03-31

投资机构B. Riley近日调整了对Centessa Pharmaceuticals plc（股票代码：CNTA）的评级，将其从"买入"下调至"中性"。与此同时，该机构将目标股价从42美元上调至45美元。

此次评级调整反映了分析师对该公司当前估值与未来发展潜力的重新评估。虽然目标价的上调显示出对长期价值的认可，但评级下调则表明短期内股价可能已接近合理区间。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1102472092?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-31 21:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102472092","market":"us","top_or_hot":-1,"title":"B. Riley将Centessa Pharmaceuticals评级从买入下调至中性，目标价上调至45美元","media":"美股速递","content":"<p>投资机构B. Riley近日调整了对Centessa Pharmaceuticals plc（股票代码：CNTA）的评级，将其从\"买入\"下调至\"中性\"。与此同时，该机构将目标股价从42美元上调至45美元。</p>\n<p>此次评级调整反映了分析师对该公司当前估值与未来发展潜力的重新评估。虽然目标价的上调显示出对长期价值的认可，但评级下调则表明短期内股价可能已接近合理区间。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>B. Riley将Centessa Pharmaceuticals评级从买入下调至中性，目标价上调至45美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nB. Riley将Centessa Pharmaceuticals评级从买入下调至中性，目标价上调至45美元\n</h2>\n\n<h4 class=\"meta\">\n\n2026-03-31 21:37 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资机构B. Riley近日调整了对Centessa Pharmaceuticals plc（股票代码：CNTA）的评级，将其从\"买入\"下调至\"中性\"。与此同时，该机构将目标股价从42美元上调至45美元。\n此次评级调整反映了分析师对该公司当前估值与未来发展潜力的重新评估。虽然目标价的上调显示出对长期价值的认可，但评级下调则表明短期内股价可能已接近合理区间。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"","article_id":"1102472092","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102472092","pubTimestamp":1774964247,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"投资机构B. Riley近日调整了对Centessa Pharmaceuticals plc（股票代码：CNTA）的评级，将其从\"买入\"下调至\"中性\"。与此同时，该机构将目标股价从42美元上调至45美元。\n此次评级调整反映了分析师对该公司当前估值与未来发展潜力的重新评估。虽然目标价的上调显示出对长期价值的认可，但评级下调则表明短期内股价可能已接近合理区间。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","CNTA":"Centessa Pharmaceuticals plc","BK4535":"淡马锡持仓"},"translate_title":"Centessa Pharmaceuticals downgraded to Neutral from Buy, price target raised to $45 at B. Riley","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNTA":1},"content_text":"投资机构B. Riley近日调整了对Centessa Pharmaceuticals plc（股票代码：CNTA）的评级，将其从\"买入\"下调至\"中性\"。与此同时，该机构将目标股价从42美元上调至45美元。\n此次评级调整反映了分析师对该公司当前估值与未来发展潜力的重新评估。虽然目标价的上调显示出对长期价值的认可，但评级下调则表明短期内股价可能已接近合理区间。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102472092","isCrawlerRequest":true}